Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
SOLV
Upturn stock ratingUpturn stock rating

Solventum Corp. (SOLV)

Upturn stock ratingUpturn stock rating
$75.46
Last Close (24-hour delay)
Profit since last BUY-0.41%
upturn advisory
Strong Buy
BUY since 28 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/27/2025: SOLV (3-star) is a STRONG-BUY. BUY since 28 days. Profits (-0.41%). Updated daily EoD!

Upturn Star Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Number of Analysts

rating

12 Analysts rated it

These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.

Year Target Price $82.17

Year Target Price $82.17

Analyst’s Price TargetsFor last 52 week
$82.17Target price
Low$47.16
Current$75.46
high$85.92

Analysis of Past Performance

Type Stock
Historic Profit 16.11%
Avg. Invested days 47
Today’s Advisory Strong Buy
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
Stock Returns Performance Upturn Returns Performance 2.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/27/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 13.06B USD
Price to earnings Ratio 34.77
1Y Target Price 82.17
Price to earnings Ratio 34.77
1Y Target Price 82.17
Volume (30-day avg) -
Beta -
52 Weeks Range 47.16 - 85.92
Updated Date 06/29/2025
52 Weeks Range 47.16 - 85.92
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) 2.17

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 4.56%
Operating Margin (TTM) 7.73%

Management Effectiveness

Return on Assets (TTM) 3.72%
Return on Equity (TTM) 10.66%

Valuation

Trailing PE 34.77
Forward PE 13.61
Enterprise Value 20434555094
Price to Sales(TTM) 1.57
Enterprise Value 20434555094
Price to Sales(TTM) 1.57
Enterprise Value to Revenue 2.46
Enterprise Value to EBITDA 15.83
Shares Outstanding 173012992
Shares Floating 138339402
Shares Outstanding 173012992
Shares Floating 138339402
Percent Insiders 20
Percent Institutions 67.82

Analyst Ratings

Rating 3.25
Target Price 82.17
Buy 2
Strong Buy 1
Buy 2
Strong Buy 1
Hold 8
Sell 1
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Solventum Corp.

stock logo

Company Overview

overview logo History and Background

Solventum Corp. was spun off from 3M in April 2024. While details about its long-term history as an independent entity are still developing, it inherits a strong legacy of innovation and expertise from its parent company, 3M, particularly in healthcare-related products and solutions.

business area logo Core Business Areas

  • Medical Solutions: Wound care, skin care, and infection prevention products used in hospitals and clinics.
  • Health Information Systems: Software and services that help healthcare providers manage patient data and improve outcomes.
  • Oral Care Solutions: Dental and orthodontic products and supplies.
  • Purification and Filtration: Filtration products used in water treatment and industrial applications.

leadership logo Leadership and Structure

Details are emerging as the company transitions into a standalone entity, however, Bryan Hanson is the CEO. The organizational structure is likely designed to support focused operations across its core business segments.

Top Products and Market Share

overview logo Key Offerings

  • Wound Care Products: Advanced wound dressings, tapes, and closures. Market share varies by product category; major competitors include Smith & Nephew, ConvaTec, and Molnlycke Health Care.
  • Dental Adhesives & Restoratives: Dental adhesives, restoratives, and cements used by dental professionals. Competitors include Dentsply Sirona and Ivoclar Vivadent.
  • Health Information Systems: Software platform and related services that allow providers to manage medical data and patient health. A competitor is Cerner/Oracle Health.

Market Dynamics

industry overview logo Industry Overview

The healthcare and industrial solutions markets are experiencing growth due to aging populations, increased healthcare spending, and demand for advanced technologies.

Positioning

Solventum is positioned as a leading provider of innovative healthcare and industrial solutions, leveraging its heritage and expertise from 3M. Its competitive advantages include a strong brand reputation and extensive distribution network.

Total Addressable Market (TAM)

The TAM across Solventum's segments is estimated to be several hundred billion dollars globally. Solventum is poised to capture a portion of this TAM by focusing on key growth areas and innovation.

Upturn SWOT Analysis

Strengths

  • Strong brand recognition inherited from 3M
  • Established distribution network
  • Diversified product portfolio
  • Expertise in healthcare and industrial markets
  • Innovation capabilities

Weaknesses

  • Newly independent company, need to establish independent identity
  • Potential for integration challenges related to separation from 3M
  • Reliance on existing patents and intellectual property
  • Limited financial data as an independent company

Opportunities

  • Expand into new geographic markets
  • Develop innovative products and solutions to address unmet needs
  • Acquire complementary businesses
  • Strengthen partnerships with healthcare providers and distributors

Threats

  • Increased competition from established players and emerging companies
  • Economic downturn affecting healthcare spending
  • Regulatory changes impacting healthcare and industrial markets
  • Disruptive technologies impacting existing product lines

Competitors and Market Share

competitor logo Key Competitors

  • JNJ
  • BSX
  • DHR
  • SYK
  • MEDP

Competitive Landscape

Solventum faces competition from larger, more established players in the healthcare and industrial markets. It can differentiate itself through innovation, product quality, and customer service.

Growth Trajectory and Initiatives

Historical Growth: Growth trends can be inferred from the historical performance of the spun-off divisions within 3M.

Future Projections: Analyst estimates will be developed as Solventum establishes its track record as an independent company.

Recent Initiatives: Focus on innovation, product development, and geographic expansion.

Summary

Solventum is a new but promising entity spun off from 3M, inheriting a strong foundation and a diverse portfolio. While it faces challenges in establishing itself as an independent company and navigating competition, its focus on innovation and growth could lead to significant opportunities. The company's success will depend on effective execution of its strategic initiatives and adapting to the evolving market dynamics.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • 3M Investor Relations
  • Solventum Investor Relations
  • Market research reports
  • Analyst reports
  • SEC Filings

Disclaimers:

The information provided is for informational purposes only and should not be construed as investment advice. Market conditions and company performance can change rapidly, and past performance is not indicative of future results.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Solventum Corp.

Exchange NYSE
Headquaters Maplewood, MN, United States
IPO Launch date 2024-03-26
CEO & Director Mr. Bryan C. Hanson
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 22000
Full time employees 22000

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wrap, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. Its Purification and Filtration segment provides purification and filtration technologies comprising filters, purifiers, cartridges, and membranes. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.